BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mirrakhimov AE, Voore P, Khan M, Ali AM. Tumor lysis syndrome: A clinical review. World J Crit Care Med 2015; 4(2): 130-138 [PMID: 25938028 DOI: 10.5492/wjccm.v4.i2.130]
URL: https://www.wjgnet.com/2220-3141/full/v4/i2/130.htm
Number Citing Articles
1
Julie C. Birch, Gaurav Khatri, Lori M. Watumull, Yull E. Arriaga, John R. Leyendecker. Unintended Consequences of Systemic and Ablative Oncologic Therapy in the Abdomen and PelvisRadioGraphics 2018; 38(4): 1158 doi: 10.1148/rg.2018170137
2
M. Launay, J. Guitton, R. Balluet, A. Moreau, J.-M. Phelip, Y. Tholance, P. Gonzalo. Clinical considerations for DPD deficiency testing in advanced cancer patients: tumor lysis syndrome should be considered as a major interferenceAnnals of Oncology 2022; 33(8): 850 doi: 10.1016/j.annonc.2022.04.073
3
Yi-Qi Su, Yi-Yi Yu, Bo Shen, Feng Yang, Yu-Xin Nie. Management of acute kidney injury in gastrointestinal tumor: An overviewWorld Journal of Clinical Cases 2021; 9(35): 10746-10764 doi: 10.12998/wjcc.v9.i35.10746
4
Mahan Shafie, Mahbod Issaiy, Mahdi Barkhori, Samaneh Parsa. Plasma cell leukemia presenting as spontaneous tumor lysis syndrome with hypercalcemiaClinical Case Reports 2022; 10(7) doi: 10.1002/ccr3.5933
5
Kevin Cao, Jesse C Wu, Michelle Hernandez, Latha Ganti. Steroid-Induced Tumor Lysis Syndrome Accompanied by Diabetic Ketoacidosis and Acute Renal Failure in a Non-Hodgkin Lymphoma Patient Cureus 2022;  doi: 10.7759/cureus.24491
6
O’Dene Lewis, Stephen M. Pastores. Oncologic Critical Care2020; : 1119 doi: 10.1007/978-3-319-74588-6_92
7
Aaron King, Thomas Maisey, Erica L. Harris, James A. Poulter, David G. Jayne, M. Ibrahim Khot. The contradictory role of febuxostat in ABCG2 expression and potentiating hypericin-mediated photodynamic therapy in colorectal cancersPhotochemical & Photobiological Sciences 2024; 23(6): 1067 doi: 10.1007/s43630-024-00575-w
8
Julie R. Ingelfinger, Mitchell H. Rosner, Mark A. Perazella. Acute Kidney Injury in Patients with CancerNew England Journal of Medicine 2017; 376(18): 1770 doi: 10.1056/NEJMra1613984
9
Aleksei Titov, Alexey Petukhov, Alena Staliarova, Dmitriy Motorin, Emil Bulatov, Oleg Shuvalov, Surinder M. Soond, Mauro Piacentini, Gerry Melino, Andrey Zaritskey, Nickolai A. Barlev. The biological basis and clinical symptoms of CAR-T therapy-associated toxicitesCell Death & Disease 2018; 9(9) doi: 10.1038/s41419-018-0918-x
10
Jorge E. Cortes, Marcos de Lima, Hervé Dombret, Elihu H. Estey, Sergio A. Giralt, Pau Montesinos, Christoph Röllig, Adriano Venditti, Eunice S. Wang. Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemiaJournal of Hematology & Oncology 2020; 13(1) doi: 10.1186/s13045-020-00975-2
11
Nazli ÖZTÜRK, Fatma ARIKAN. Tümör Lizis Sendromunda Hemşirelik YaklaşımıOrdu Üniversitesi Hemşirelik Çalışmaları Dergisi 2021; 4(1): 113 doi: 10.38108/ouhcd.782461
12
C. Baudon, F. P. Duhoux, I. Sinapi, J. L. Canon. Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case reportJournal of Medical Case Reports 2016; 10(1) doi: 10.1186/s13256-016-0969-5
13
Elizabeth Mary Durfee. Tumor Lysis SyndromeCritical Care Nurse 2022; 42(3): 19 doi: 10.4037/ccn2022795
14
Houssein Abdul Sater. A Case Report of Inflammatory Syndrome Presenting as Tumor Lysis Syndrome after Single Dose of NivolumabJournal of Cancer Prevention & Current Research 2017; 8(2) doi: 10.15406/jcpcr.2017.08.00271
15
Rahul V. Parghane, Sandip Basu. Toxicity manifestations encountered in peptide receptor radionuclide therapy settingJournal of Neuroendocrinology 2024;  doi: 10.1111/jne.13464
16
H. Taghvaye Masoumi, M. Hadjibabaie, M. Zarif-Yeganeh, O. Arasteh. Exacerbation of allopurinol-induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: A case reportJournal of Clinical Pharmacy and Therapeutics 2017; 42(5): 642 doi: 10.1111/jcpt.12556
17
Cindy Pabon, Ashwini K Esnakula, Karen Daily. Tumour lysis syndrome following eribulin for metastatic uterine leiomyosarcomaBMJ Case Reports 2018; 11(1): e224576 doi: 10.1136/bcr-2018-224576
18
Annalisa Noce, Giulia Marrone, Manuela Di Lauro, Anna Paola Mitterhofer, Maria Josè Ceravolo, Nicola Di Daniele, Guglielmo Manenti, Antonino De Lorenzo. The Onco-Nephrology Field: The Role of Personalized Chemotherapy to Prevent Kidney DamageCancers 2023; 15(8): 2254 doi: 10.3390/cancers15082254
19
Ioannis Bellos, Konstantinos Kontzoglou, Amanda Psyrri, Vasilios Pergialiotis. Febuxostat administration for the prevention of tumour lysis syndrome: A meta‐analysisJournal of Clinical Pharmacy and Therapeutics 2019;  doi: 10.1111/jcpt.12839
20
Craig Nolan, Lisa M. DeAngelis. The confused oncologic patient: a rational clinical approachCurrent Opinion in Neurology 2016; 29(6): 789 doi: 10.1097/WCO.0000000000000392
21
Allen T. Gordon, Olufunso O. Abosede, Songeziwe Ntsimango, Eric C. Hosten, Nonzuzo Myeza, Armorel van Eyk, Leonie Harmse, Adeniyi S. Ogunlaja. Synthesis and anticancer evaluation of copper(II)- and manganese(II)- theophylline mixed ligand complexesPolyhedron 2022; 214: 115649 doi: 10.1016/j.poly.2022.115649
22
Mitchell H. Rosner, Giovambattista Capasso, Mark A. Perazella. Acute kidney injury and electrolyte disorders in the critically ill patient with cancerCurrent Opinion in Critical Care 2017; 23(6): 475 doi: 10.1097/MCC.0000000000000450
23
Reeti Kumar, Suzanne Reed, Joseph R. Stanek, John D. Mahan. Defining kidney outcomes in children with acute lymphoblastic leukemia in the modern eraPediatric Nephrology 2022; 37(9): 2119 doi: 10.1007/s00467-021-05402-3
24
Reeti Kumar, John D. Mahan, Joseph R. Stanek, Suzanne Reed. Extent of hypertension and renal injury in children surviving acute lymphoblastic leukemiaPediatric Blood & Cancer 2022; 69(9) doi: 10.1002/pbc.29628
25
Lamis Hani Elkhatib, Mohamed Salaheldin Bayoumy, Abdulatef Mohammed Ahmed, Muhammad Matloob Alam, Ibraheem Faisal Abosoudah, Hassan Ali Altrabolsi. Tumor Lysis Syndrome in Pediatric Patients with Hematological MalignanciesJournal of Applied Hematology 2022; 13(3): 118 doi: 10.4103/joah.joah_243_20
26
Maciej Stawny, Aleksandra Gostyńska, Alina Górecka, Dorota Mańkowska, Izabela Kołodziej, Hanna Jankowiak-Gracz, Magdalena Ogrodowczyk. Stability studies of two compounded solutions potentially used in tumor lysis syndromeJournal of Oncology Pharmacy Practice 2019; 25(6): 1434 doi: 10.1177/1078155219840421
27
Jasper Rathinam J, Thomas Isiah Sudarsan. Critical Care Hematology2024; : 439 doi: 10.1007/978-981-97-5565-3_32
28
Norbert Lameire, Raymond Vanholder, Wim Van Biesen, Dominique Benoit. Acute kidney injury in critically ill cancer patients: an updateCritical Care 2016; 20(1) doi: 10.1186/s13054-016-1382-6
29
Bruce D. Cheson, Sari Heitner Enschede, Elisa Cerri, Monali Desai, Jalaja Potluri, Nicole Lamanna, Constantine Tam. Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted AgentsThe Oncologist 2017; 22(11): 1283 doi: 10.1634/theoncologist.2017-0055
30
Alaa M. Ali, Aibek E. Mirrakhimov, Camille N. Abboud, Amanda F. Cashen. Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digestHematological Oncology 2016; 34(2): 69 doi: 10.1002/hon.2292
31
Songpon Getsuwan, Patcharee Komwilaisak, Napat Laoaroon, Patchareeporn Tanming, Kunanya Suwannaying, Surapon Wiangnon, Arunee Jetsrisuparb. Intestinal obstruction from calcium polystyrene sulfonate in pediatric cancer patientsPediatric Hematology Oncology Journal 2022; 7(4): 122 doi: 10.1016/j.phoj.2022.07.001
32
Walid Macaron, Zaven Sargsyan, Nicholas J. Short. Hyperleukocytosis and leukostasis in acute and chronic leukemiasLeukemia & Lymphoma 2022; 63(8): 1780 doi: 10.1080/10428194.2022.2056178
33
Partow Kebriaei, Corey Cutler, Marcos de Lima, Sergio Giralt, Stephanie J. Lee, David Marks, Akil Merchant, Wendy Stock, Koen van Besien, Matthias Stelljes. Management of important adverse events associated with inotuzumab ozogamicin: expert panel reviewBone Marrow Transplantation 2018; 53(4): 449 doi: 10.1038/s41409-017-0019-y
34
Ninotchka Brydges, Garry J. Brydges. Oncologic EmergenciesAACN Advanced Critical Care 2021; 32(3): 306 doi: 10.4037/aacnacc2021832
35
Helen H. Chung, Elina Tsyvkin. Tumor Lysis SyndromeHospital Medicine Clinics 2016; 5(3): 425 doi: 10.1016/j.ehmc.2016.02.004
36
Florian Scurt, Lothar Schrod. Klinische Notfallmedizin Band 1 Wissen2020; : 482 doi: 10.1016/B978-3-437-23248-0.00044-4
37
David F. Kisor. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process2020;  doi: 10.21019/9781582123127.ch20
38
Shuiying Liu, Jinyuan Zhao, Feng Wang. Acute kidney injury in cancer patientsClinical and Experimental Nephrology 2022; 26(2): 103 doi: 10.1007/s10157-021-02131-7
39
Kris M. Mahadeo, Francesco Paolo Tambaro, Cristina Gutierrez. Chimeric Antigen Receptor T-Cell Therapies for Cancer2020; : 65 doi: 10.1016/B978-0-323-66181-2.00006-8
40
E Araúz-Valdés, L Fernández-Castañeda , E D’Orcy. Tumor de tejidos blandos como presentación atípica de linfoma de Burkitt esporádico. Reporte de casoRevista Hematología 2024; 27(3) doi: 10.48057/hematologa.v27i3.539
41
Shivakumar Shivanna, Indira Menon, Rajeshwari T Nagaraju, Swapna B Mandala, Rohith G Chitrapur. Insights into Uncommon Presentation—Acute T-cell Lymphoma with Mediastinal Mass and Pericardial Effusion: Exploring the Rare Phenomenon of Spontaneous Tumor LysisIndian Journal of Critical Care Case Report 2024; 3(3): 57 doi: 10.5005/jp-journals-11006-0107
42
Robert Chapman, Sita Shah, Alberto D’Angelo. Acute kidney injury following induction of chemotherapy: Diagnosis and management in critical careJournal of the Intensive Care Society 2023; 24(1): 112 doi: 10.1177/17511437221106441
43
B. L. Ferreyro, L. Munshi. Annual Update in Intensive Care and Emergency Medicine 2019Annual Update in Intensive Care and Emergency Medicine 2019; : 31 doi: 10.1007/978-3-030-06067-1_3
44
Aurélien Mary, Amélie Boursier, Michel Brazier, Patrice Fardellone. Pharmacie Clinique et Thérapeutique2018; : 303 doi: 10.1016/B978-2-294-75077-9.00020-7
45
Julie Beaume, Antoine Braconnier, Thibault Dolley-Hitze, Jean-Philippe Bertocchio. Bicarbonate : de la physiologie aux applications thérapeutiques pour tout clinicienNéphrologie & Thérapeutique 2018; 14(1): 13 doi: 10.1016/j.nephro.2017.02.014
46
Matthew Abramson, Ali Mehdi. Hematological Malignancies and the KidneyAdvances in Chronic Kidney Disease 2022; 29(2): 127 doi: 10.1053/j.ackd.2022.02.003
47
Marta Romo-González, Sara Moreno-Paz, Violeta García-Hernández, Fermín Sánchez-Guijo, Ángel Hernández-Hernández. Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid LeukemiaAntioxidants 2020; 9(1): 74 doi: 10.3390/antiox9010074
48
Nadia Taha, Gopika Bhaskar. Spontaneous Tumour Lysis Syndrome in Mantle Cell Lymphoma: A Case StudyCureus 2022;  doi: 10.7759/cureus.29851
49
O’Dene Lewis, Stephen M. Pastores. Oncologic Critical Care2019; : 1 doi: 10.1007/978-3-319-74698-2_92-1
50
Ameneh Jafari, Mostafa Rezaei-Tavirani, Maryam Salimi, Reza Tavakkol, Zahra Jafari. Oncological Emergencies from Pathophysiology and Diagnosis to Treatment: A Narrative ReviewSocial Work in Public Health 2020; 35(8): 689 doi: 10.1080/19371918.2020.1824844
51
Daniel Pindak, Katarina Rejlekova, Miroslav Tomas, Ramadan Aziri, Eva Rovenska, Judita Puskacova, Michal Mego. Intraoperative tumor lysis syndrome in a giant teratoma: a case reportBMC Surgery 2019; 19(1) doi: 10.1186/s12893-019-0526-4
52
Chinatsu Kurasaka, Nana Nishizawa, Yoko Ogino, Akira Sato. Anticancer sensitivity and biological aspect of 5-fluorouracil-resistant human colorectal cancer HCT116 cells in three-dimensional culture under high- and low-glucose conditionsNucleosides, Nucleotides & Nucleic Acids 2024; 43(8): 870 doi: 10.1080/15257770.2024.2332414
53
Gianfilippo Nifosì. Hematologic EmergenciesOpen Journal of Internal Medicine 2016; 6(03): 83 doi: 10.4236/ojim.2016.63014
54
V.I. Potievskaya, A.A. Akhobekov. Classification of cardio-oncology syndromes in assessing the interaction of cardiovascular diseases and cancerKardiologiya i serdechno-sosudistaya khirurgiya 2023; 16(5): 529 doi: 10.17116/kardio202316051529
55
Philip R Cohen, Victor G Prieto, Razelle Kurzrock. Tumor Lysis Syndrome: Introduction of a Cutaneous Variant and a New Classification SystemCureus 2021;  doi: 10.7759/cureus.13816
56
Athanasios Tragiannidis, Maria Papageorgiou, Maria Stamou, Emmanuel Hatzipantelis, Theodotis Papageorgiou, Andreas Giannopoulos, Lamprini Damianidou, Anna Pappa, Stiliani Pappa, Maria Hatzistilianou. Tumor lysis-like syndrome in a child during treatment for visceral leishmaniasisInternational Journal of Immunopathology and Pharmacology 2016; 29(3): 458 doi: 10.1177/0394632016640788
57
Ricardo Ambrósio Rodrigues, Telma Alves, Christine Joannie Canizes Paiva, João Rocha Gonçalves. Acute flaccid paralysis due to multifactorial hyperkalaemiaBMJ Case Reports 2023; 16(6): e255608 doi: 10.1136/bcr-2023-255608
58
Emily L. Joyce, Sandra L. Kane-Gill, Dana Y. Fuhrman, John A. Kellum. Drug-associated acute kidney injury: who’s at risk?Pediatric Nephrology 2017; 32(1): 59 doi: 10.1007/s00467-016-3446-x
59
Wiebke Wesemüller, Christian Taverna. Spontaneous Tumor Lysis SyndromeCase Reports in Oncology 2020; 13(3): 1116 doi: 10.1159/000509643
60
Michail Papapanou, Anastasios E. Athanasopoulos, Eleni Georgiadi, Stefanos A. Maragkos, Michalis Liontos, Dimitrios C. Ziogas, Dimitrios Damaskos, Dimitrios Schizas. Spontaneous tumor lysis syndrome in patients with solid tumors: a scoping review of the literatureMedical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02108-4
61
Shaunak Navalkissoor, Christos Toumpanakis, Martyn Caplin, Gopinath Gnanasegaran. Treatment of neuroendocrine tumours with 177Lu‐peptide receptor radionuclide therapy: Challenging clinical scenarios and their managementJournal of Neuroendocrinology 2022; 34(4) doi: 10.1111/jne.13088
62
Benjamin Rahmani, Shrey Patel, Omar Seyam, Jason Gandhi, Inefta Reid, Noel Smith, Sardar Ali Khan. Current understanding of tumor lysis syndromeHematological Oncology 2019; 37(5): 537 doi: 10.1002/hon.2668
63
Elżbieta Iskierka-Jażdżewska, Tadeusz Robak. Minimizing and managing treatment-associated complications in patients with chronic lymphocytic leukemiaExpert Review of Hematology 2020; 13(1): 39 doi: 10.1080/17474086.2020.1696185
64
Ales Groselj, Masa Bosnjak, Primoz Strojan, Mojca Krzan, Maja Cemazar, Gregor Sersa. Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary resultsHead & Neck 2018; 40(1): 120 doi: 10.1002/hed.24991
65
Kai Huang, Winfried Brenner, Vikas Prasad. Tumor Lysis Syndrome: A Rare but Serious Complication of Radioligand TherapiesJournal of Nuclear Medicine 2019; 60(6): 752 doi: 10.2967/jnumed.118.217380
66
Vivek Alaigh, Debapriya Datta. Spontaneous Tumor Lysis Syndrome due to Uterine Leiomyosarcoma with Lung MetastasesCase Reports in Critical Care 2017; 2017: 1 doi: 10.1155/2017/4141287
67
Marta Skoczyńska, Małgorzata Chowaniec, Anna Szymczak, Anna Langner-Hetmańczuk, Beata Maciążek-Chyra, Piotr Wiland. Pathophysiology of hyperuricemia and its clinical significance – a narrative reviewRheumatology 2020; 58(5): 312 doi: 10.5114/reum.2020.100140
68
John R. Carr, W. Anthony Hawkins, Andrea Sikora Newsome, Susan E. Smith, Clemmons Amber B, Christopher M. Bland, Trisha N. Branan. Fluid Stewardship of Maintenance Intravenous FluidsJournal of Pharmacy Practice 2022; 35(5): 769 doi: 10.1177/08971900211008261
69
Phyo Thazin Myint, Hifza Waheed Butt, Taha Alrifai, Carlos Marin. Spontaneous Tumor Lysis Syndrome Secondary to Small-Cell Neuroendocrine Carcinoma of Unknown Origin: A Rare Case Report and Literature ReviewCase Reports in Oncological Medicine 2019; 2019: 1 doi: 10.1155/2019/6375693
70
Pamela Carvalho Muniz, Mayndra Mychelle Landgraf, Fernando Silva Picon, Hakaru Tadokoro, Ramon Andrade De Mello, Michelle Samora de Almeida. International Manual of Oncology Practice2019; : 945 doi: 10.1007/978-3-030-16245-0_42
71
Shahrier Hossain, Martha Naber, Matthew J Yacobucci. A retrospective observational study of a low fixed-dose rasburicase protocol for the treatment of tumor lysis syndrome in adultsJournal of Oncology Pharmacy Practice 2022; 28(6): 1326 doi: 10.1177/10781552211021147
72
Ivanka Percic. Tumor lysis syndromeMedicinski pregled 2022; 75(Suppl. 1): 157 doi: 10.2298/MPNS22S1157P
73
Praveen Dhyani, Cristina Quispe, Eshita Sharma, Amit Bahukhandi, Priyanka Sati, Dharam Chand Attri, Agnieszka Szopa, Javad Sharifi-Rad, Anca Oana Docea, Ileana Mardare, Daniela Calina, William C. Cho. Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamineCancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02624-9
74
Sharleen Yuan, Samantha J. Yarmis, Kami M. Hu. Oncologic Emergency Medicine2021; : 481 doi: 10.1007/978-3-030-67123-5_36
75
Janja Tarčuković, Lara Valenčić, Željka Polonijo, Ana Fućak, Boban Dangubić, Igor Grubješić. Acute Liver Failure as the Leading Manifestation of Spontaneous Tumour Lysis Syndrome in a Patient with NonHodgkin Lymphoma: Do Current Diagnostic Criteria of Tumour Lysis Syndrome Need Re-Evaluation?Case Reports in Critical Care 2019; 2019: 1 doi: 10.1155/2019/2358562
76
Hydration effect on kidney function and serum electrolyte in children with tumor lysis syndrome (TLS) and risk of TLSJournal of Basic and Clinical Physiology and Pharmacology 2021; 32(4): 603 doi: 10.1515/jbcpp-2020-0412
77
Mitchell H. Rosner, Mark A. Perazella. Acute kidney injury in the patient with cancerKidney Research and Clinical Practice 2019; 38(3): 295 doi: 10.23876/j.krcp.19.042
78
Adnan Humam Waseem Hajjar, Shahem Abbarh, Abdulrahman Al-Mashdali, Awni Alshurafa, Mohammad Abu-Tineh, Hana Qasim, Khalid Ahmed, Mohamed A Yassin. Tumor Lysis Syndrome in the Chronic Phase of Chronic Myeloid Leukemia Following COVID-19 Infection: A Case ReportCureus 2022;  doi: 10.7759/cureus.24386
79
Jen DeSalvo, Allison L Rossetti. Infection Masquerading As Spontaneous Tumor Lysis SyndromeCureus 2023;  doi: 10.7759/cureus.40503
80
Hoda Pourhassan, Waasil Kareem, Vaibhav Agrawal, Ibrahim Aldoss. Important Considerations in the Intensive Care Management of Acute LeukemiasJournal of Intensive Care Medicine 2024; 39(4): 291 doi: 10.1177/08850666231193955
81
Saurabh Vig, Seema Mishra, Kanika Rustagi, Swati Bhan. Opioid toxicity with underlying tumour lysis syndrome in a patient with CMML: a diagnostic and therapeutic challengeBMJ Case Reports 2018; : bcr-2018-225646 doi: 10.1136/bcr-2018-225646
82
Tao Zhou, Jianfang Zhu, Dan Shang, Chuxing Chai, Youzhen Li, Haiying Sun, Yongqin Li, Meng Gao, Min Li. Mitochondria-anchoring and AIE-active photosensitizer for self-monitored cholangiocarcinoma therapyMaterials Chemistry Frontiers 2020; 4(11): 3201 doi: 10.1039/D0QM00503G
83
Eslam E. Abd El-Fattah. Tumor lysis syndrome promotes cancer chemoresistance and relapse through AMPK inhibitionInternational Immunopharmacology 2023; 114: 109568 doi: 10.1016/j.intimp.2022.109568
84
Lorenzo Gianni, Maria Vittoria Stefania Nicoletti, Valentina Arcangeli. Breast Cancer2017; : 697 doi: 10.1007/978-3-319-48848-6_58
85
Beenish Faheem, Sudarsan Kollimuttathuillam, Hamdallah Ashkar, Michael Maroules. Spontaneous Tumor Lysis Syndrome in T-Cell LeukemiaCureus 2020;  doi: 10.7759/cureus.11002
86
Tidapa Rattanaumpa, Santi Maensiri, Kamonwad Ngamchuea. Microporous carbon in the selective electro-oxidation of molecular biomarkers: uric acid, ascorbic acid, and dopamineRSC Advances 2022; 12(29): 18709 doi: 10.1039/D2RA03126D
87
David F. Kisor. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process, 2nd Edition2022;  doi: 10.21019/9781582123844.ch21
88
Seiya Urae, Kayori Tsuruoka, Sayaka Kuroya, Yugo Shibagaki. Tumor Lysis-like Syndrome in Eosinophilic Disease of the Lung: A Case Report and Review of the LiteratureInternal Medicine 2016; 55(20): 3029 doi: 10.2169/internalmedicine.55.6659
89
Nicole Gri, Yaroslava Longhitano, Christian Zanza, Valentina Monticone, Damiano Fuschi, Andrea Piccioni, Abdelouahab Bellou, Ciro Esposito, Iride Francesca Ceresa, Gabriele Savioli. Acute Oncologic Complications: Clinical–Therapeutic Management in Critical Care and Emergency DepartmentsCurrent Oncology 2023; 30(8): 7315 doi: 10.3390/curroncol30080531
90
Olivia Sherwen, Madeleine Kate Baron, Natalie Strachan Murray, Paul Anthony Heaton, Jane Gamble, Siba Prosad Paul. The recognition and nursing management of common oncological emergencies in childrenBritish Journal of Nursing 2022; 31(1): 20 doi: 10.12968/bjon.2022.31.1.20
91
Suet Ying Lam, Eugene Yu-hin Chan, Frankie Wai Tso Cheng, Alison Lap Tak Ma, Shau Yin Ha. Acute kidney injury in children with haematological malignancy: a territory-wide studyPediatric Nephrology 2023; 38(11): 3823 doi: 10.1007/s00467-023-06010-z
92
Dominic J. Fowler-Shorten, Charlotte Hellmich, Matthew Markham, Kristian M. Bowles, Stuart A. Rushworth. BCL-2 inhibition in haematological malignancies: Clinical application and complicationsBlood Reviews 2024; 65: 101195 doi: 10.1016/j.blre.2024.101195
93
Rudolf A. de Boer, Joseph Pierre Aboumsallem, Valentina Bracun, Douglas Leedy, Richard Cheng, Sahishnu Patel, David Rayan, Svetlana Zaharova, Jennifer Rymer, Jennifer M. Kwan, Joshua Levenson, Claudio Ronco, Paaladinesh Thavendiranathan, Sherry-Ann Brown. A new classification of cardio-oncology syndromesCardio-Oncology 2021; 7(1) doi: 10.1186/s40959-021-00110-1